Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
Israel Becomes First Country to Approve Medical Cannabis Vaporizers
Error: Contact form not found.
by JNS.org
Medical cannabis at Israel’s third annual CannaTech conference in March 2017. Photo: Adam Abrams.
JNS.org – Israel has become the world’s first country to approve cannabis vaporizers for medical use.
The Israeli Ministry of Health has granted initial approval to the VapePod vaporizer developed by Kanabo Research, a Tel-Aviv-based medical cannabis research and development company, according to a report by Israel21c.
Most medical marijuana patients receive the benefits of cannabis from smoking. The approved vaporizer will free users from the detriments of smoking and deliver consistent, accurate dosing in a more effective manner.
“We expect that due to the transition of most of the cannabis consumers to the use of vaporizers, our company is projected to reach $10 million in sales within three years in the Israeli market, while the Israeli cannabis market is expected to reach $100 million in sales within three years, Avihu Tamir, cofounder and CEO of Kanabo Research said. “The Israeli market is a platform to deliver our technology to global markets in North America and Europe.”
The organization is currently performing preclinical trials to treat sleep disorders with VapePod.
